Valuation: Gedeon Richter

Market Cap 2,198B 7.05B 6.17B 5.7B 5.31B 10.01B 667B 10.19B 68.34B 26.53B 329B 26.49B 25.9B 1,146B P/E 2026 *
8.42x
P/E 2027 * 7.72x
Enterprise Value 1,883B 6.04B 5.29B 4.88B 4.55B 8.58B 571B 8.73B 58.56B 22.73B 282B 22.7B 22.19B 982B EV / Sales 2026 *
1.98x
EV / Sales 2027 * 1.74x
Free-Float
72.87%
Yield 2026 *
5.15%
Yield 2027 * 5.51%
1 week+0.83%
Current month-5.27%
1 month-5.27%
3 months+10.49%
6 months+31.41%
Current year+31.41%
1 week 33
Extreme 33
34.94
1 month 32.5
Extreme 32.5
36.56
Manager TitleAgeSince
Chief Executive Officer 47 01/11/2017
Director of Finance/CFO - 01/05/2025
Chief Operating Officer - 01/01/2019
Director TitleAgeSince
Chairman 78 01/01/2017
Chairman 90 01/03/2024
Director/Board Member 65 26/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+0.83%+36.34% - 7.05B
+0.20%-0.44%+11.94%+80.71% 47.26B
-1.30%-1.89%+56.15%+101.61% 35B
-0.59%+1.31%-3.89%+45.41% 12.52B
-0.31%+0.90%+10.64%+91.77% 11.74B
+2.30%-2.72%+29.46%+115.95% 8.67B
-0.84%+0.77%+53.82%-9.05% 6.9B
-1.92%-0.86%+23.23%+227.83% 6.58B
-3.07%+2.87%-32.62%+2.24% 5.23B
-2.20%+2.82%+33.76%+126.95% 4.52B
Average -0.86%+1.42%+21.88%+87.05% 15.38B
Weighted average by Cap. -0.52%+0.64%+24.91%+87.01%

Financials

2026 *2027 *
Net sales 952B 3.05B 2.67B 2.47B 2.3B 4.34B 289B 4.41B 29.59B 11.49B 142B 11.47B 11.22B 496B 1,024B 3.28B 2.87B 2.65B 2.48B 4.66B 310B 4.75B 31.83B 12.36B 153B 12.34B 12.06B 534B
Net income 259B 832M 729M 673M 627M 1.18B 78.71B 1.2B 8.07B 3.13B 38.84B 3.13B 3.06B 135B 286B 918M 804M 742M 692M 1.3B 86.81B 1.33B 8.9B 3.45B 42.84B 3.45B 3.37B 149B
Net Debt -315B -1.01B -883M -816M -761M -1.43B -95.43B -1.46B -9.78B -3.8B -47.09B -3.79B -3.71B -164B -421B -1.35B -1.18B -1.09B -1.02B -1.92B -128B -1.95B -13.1B -5.09B -63.08B -5.08B -4.97B -220B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
-
Date Price Change
01/07/26 EUR 34.34 +0.59%
30/06/26 EUR 34.14 -0.47%
29/06/26 EUR 34.30 -0.23%
26/06/26 EUR 34.38 +0.29%
25/06/26 EUR 34.28 +0.82%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,050.00HUF
Average target price
12,931.29HUF
Spread / Average Target
+7.31%

Quarterly revenue - Rate of surprise